Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 732.36

+4.2%

12:49 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (582)	10/23/2001 8:39:09 PM
From: Miljenko Zuanic	Read Replies (1) of 3559

<<BTW, will see how will CBST fire after note offering?>> The notes are convertible into Cubist's common stock at a conversion price of $47.20 per share, …10% premium. Not bad, definitely much better that REGN convertible. REGN CFO should consider RESIGNATION, without single option left, jimho. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next